Additionally, cardioprotective effect of rosuvastatin in DCM rats was abrogated with NLRP3-miRNA treatment confirming the essential role of NLRP3 inflammasome in DCM model (Sun and Ding 2021). Here, NLRP3 is linked to familial dilated cardiomyopathy.